story : US Stem Cells Tainted by Mouse Material
story : Blood Transplants Riskier Than Bone Marrow Transplants In Pediatric Leukemia Patients
Hair Cloning Nears Reality as Baldness Cure
Researchers Grow Sperm Stem Cells in Laboratory Cultures
Advance Could Lead To New Infertility Treatments, Source of Adult Stem Cells
Article 1, Article 2, Article 3, Article 4
Stem Cells Engineered to Attack Cancer
Article 1, Article 2, Article 3
Biochemists At U.Virginia Health System Identify Molecular Switch That Regulates Cancer Cell Survival
Antisoma Telomere Targeting Agent Stops Tumour Growth In Prostate Cancer Model
Interim Phase 2 Data Suggest Activity of Panitumumab with Chemotherapy in First-Line Treatment of Metastatic Colorectal Cancer
Allergy Link to Blood Cancer Risk
Stem Cells Found in Adult Skin Retain their Embryonic Capability of Making Many Types of Cells
New Hope For ALS Seen With Genetic Techniques, Growth Factors
Cell Transplants Restore Lost Skin Color
Retinal Stem Cells Can Regenerate After Transplant
Certain Diseases May Affect Success of Stem Cell Transplants
Endocrinologists See Hope for Stem Cell Use as Diabetes Cure
Link Between Immune Protein And Longer Survival In Melanoma Patients Identified
Hollis-Eden Pharmaceuticals Describes New Data with Potent Second Generation Immune Regulating Hormones in Preclinical Models of Autoimmune and Inflammatory Conditions
Doubt Over Stem Cell Blood Theory
Promises and Perils of Genetic Engineering
Promise Of Stem Cells Amplified; New Evidence Shows Cells May Help Treat Many Disorders Including Paralysis And Brain Cancer
Human Genome Sciences Characterizes Panel Of Novel Human Monoclonal Antibodies That Specifically Antagonize The CCR5 Receptor And Block HIV-1 Entry
Embryos to be Screened for Cancer
Watchdog Faces Questions about Approval for 'Designer Baby' Tests
Stem Cells: Saving Lives or Crossing Lines
Conference at Rice University November 20-21 will address ways to better inform the American public about the importance of a US role in human embryonic stem cell research
ABSTRACTS, REVIEWS, & SPECIAL REPORTS
Higher Mortality After Allogeneic Peripheral-Blood Transplantation Compared With Bone Marrow in Children and Adolescents: The Histocompatibility and Alternate Stem Cell Source Working Committee of the International Bone Marrow Transplant Registry
Autologous Peripheral Blood Stem Cell Transplantation for Myocardial Regeneration: A Novel Strategy for Cell Collection and Surgical Injection
Cellular Sources of New Pancreatic Cells and Therapeutic Implications for Regenerative Medicine
Clinical Strategies for the Expanson of Haematopoietic Stem Cells
Derivation and Characterisation of New Human Embryonic Stem Cell Lines in Czech Republic
Gene Transfer of Constitutively Active Caspase-3 Induces Apoptosis in a Human Hepatoma Cell Line
Haematopoietic Stem Cell Transplantation in Europe 2002:
Changes in indication and impact of team density.
LRP6 Expression Promotes Cancer Cell Proliferation and Tumorigenesis by Altering -Catenin Subcellular Distribution
Making Structures for Cell Engineering
New and Viable Cells to Replace Lost and Malfunctioning Myocardial Tissueiable Cells
Opinion: The nature of stem cells: state rather than entity
Isolation and Expansion of Adult Cardiac Stem Cells From Human and Murine Heart
Strategies to Enhance T-Cell Reconstitution in Immunocompromised Patients
Student Society for Stem Cell Research: Global Petition to the UN for Stem Cell Research
UN Delays Vote on Cloning Ban — Again
Experts: Stem cell Research May Get Post-Election Boost
California Voters Back $3 Billion Stem Cell Measure
Article 1, Article 2, Article 3
National Academies of Science Guidelines for Human Embryonic Stem Cell Research
CalbaTech Announces Creation of New Subsidiary LifeStem; Believes Its Stem Cell Research Programs and Proprietary Stem Cell Delivery System Will Benefit From Passage of Proposition 71, California's $3 Billion Stem Cell Research Program
Chemicon International Inc., A Division Of Serologicals Corporation, Acquires Mouse Embryonic Stem Cell Product Lines From Primogenix Incorporated
Chemicon and Thromb-X N.V. Enter Into Agreement for Exclusive Sale and Marketing of New Embryonic Stem Cell Tissue Culture Media
Dendreon Achieves Commercial Scale of Antigen for Provenge
Genzyme Seeks Therapeutic Indication for Thyrogen
Immucor Under Investigation for Allegedly Making Improper Payments
Mederex's Mice Produce Human Antibodies
Peptimmune, Inc. Announces Promotion Of Thomas P. Mathers To CEO
Search For New Medicines In Cancer, HIV, Hepatitis, Blindness And Diabetes/Obesity
Progenics Pharmaceuticals, Inc. and Cytogen Corporation Announce Award Of $7.4 Million In NIH Grants For Prostate Cancer Immunotherapies
StemCells Completes Equity Financing; $22.5 Million in Funds to Support Batten's Trial
ThermoGenesis Submits to FDA for Permission to Market the DAC(TM) System for Separating Blood Components
Vistagen Secures More Key Embryonic Stem Cell Technology For Leading Edge Diabetes Research
Malachite Management has joined forces with an established and reputable author to bring you a report outlining the very latest in the Cell Therapy industry. "Cell Therapy - Technologies, Markets, and Companies" is over 400 pages of the basic technologies, clinical applications, market analysis, and company profiles related to the cell therapy industry worldwide.
For more information and to order see:
Malachite Management has joined forces with an established and reputable author to bring you a report outlining the very latest in the Gene Therapy industry. "Gene Therapy - Technologies, Markets and Companies" is 560 pages of the basic technologies, clinical applications, market analysis, and company profiles related to the gene therapy industry worldwide.
For more information and to order see:
Gene Therapy Report Summary
Gene Therapy Table of Contents Vol. 1 Vol. 2
Gene Therapy Order Form
Malachite Management Inc. has teamed up with an established publisher to bring you the latest reports in immunotherapeutic approaches to cancer. For more information and to order see:
A Shift in Cancer Immunotherapy Stategies?
Immunotherapy Strategies Executive Summary
Immunotherapy Strategies Table of Contents
Future Perspectives in Cancer Immunotherapy
Future Perspectives Executive Summary
Future PerspectivesTable of Contents
Immunotherapy Reports Order Form
NATIONAL INSTITUTES OF HEALTH
NIH to Designate Three Centers for Regenerative Medicine Research
Centers of Excellence in Translational Human Stem Cell Research
RFA Number: RFA-NS-05-005
National Institute of Allergy and Infectious Diseases
HLA Region Genetics in Immune-Mediated Diseases - Addendum to RFA-AI-04-039
National Institute of Allergy and Infectious Diseases Health Resources and Services Administration; National Heart, Lung, and Blood Institute; National Institute of Diabetes and Digestive and Kidney Diseases
Request for Information (RFI): Live Organ Donor Outcomes and Medical Needs
All new CBER information can be reached from the What's New page
Substantially Equivalent 510(k) Device - Misys Laboratory Blood Bank and Blood Donor 6.0.1 - Misys Healthcare Systems
Posted: 10/29/2004, Clearance Date: 10/22/2004
Human Blood and Blood Components Intended for Transfusion or for Further Manufacture
Exceptions and Alternative Procedures Approved Under 21 CFR 640.120 - Update
Posted: 10/28/2004, Updated through: 10/28/2004
Draft Guidance for Industry: Criteria for Safety and Efficacy Evaluation of Oxygen Therapeutics as Red Blood Cell Substitutes
Posted: 10/28/2004, Publish Date: 10/28/2004
ISPE Regulatory Information (International regulatory agencies and documents)
International Conference on Harmonisation (ICH) Guidances - Topics and Guidelines
The 21CFRPart11.com Web site provides access to information on the rules and also maintains an email list that actively discusses issues and concerns with industry peers and government regulators.
Regulatory Affairs Professionals Society
RAPS Combination Products Resource Page.
The United States Food & Drug Agency
Investigations Operations Manual 2004
Medical Device GMP Reference Information
Modernization Act of 1997 (FDAMA)
OTHER REGULATORY RESOURCES
Tooth Tissue Engineering and the Quest for Dental Stem Cells
Guest Speaker: Dr. Conan S. Young from the Forsyth Institute (Boston, USA)
Date: November 15th, 2004
Time: 10:30AM-11:30AM PST
Location: Terry Fox Institute (in the BCCR Lecture Theatre)
601 West 10th Avenue, Vancouver, BC
Contact: 604-877-0713 or email@example.com
For a more complete listing of conferences, see Malachite Management's new online, interactive Cell Therapy Calendar
OTHER ONLINE CALENDARS
CONFERENCES 2004Nov. 10 Lecture: Life After Darwin: the Open Softrware of Gene Therapy. New Jersey Institute of Technology
Nov.18-19 Commercialisation of Tissue Engineering and Regenerative Medicine. London, UK.
Nov. 19 Advances In Bone Marrow Transplantation Conference- Sydney Australia
Nov. 19 - 21 2004 Hanson Symposium "Stem Cells: From Biology to Therapy" Adelaide, South Australia.
Nov. 20-22 33rd Annual Autumn Immunology Conference .Chicago, Illnois
Nov 20-22 Stem Cells: Saving Lives or Crossing Lines.Rice University, Houston, Texas
Nov. 22-24 2nd National Stem Cell Centre Annual Scientific Conference. Sydney, Australia.
Nov 30-Dec 3 IBC's 2nd Annual Antibody Therapeutics.San Diego, California
Nov 30-Dec 3 IBC's 15th Annual Antibody Engineering. San Diego, California
Dec. 1-3 Immunogenicity for Protein-Based Therapeutics - Washington, DC
Dec. 3 Cellular Therapy: Progressing to Clinical Practice?- San Diego Marriott Hotel & Marina, San Diego, CA
Dec. 3-7 Amer. Society for Hematology: 46th Annual Mtg - San Diego, California - San Diego, CA
Dec. 4-8 American Society for Cell Biology (ASCB) 44th Annual Meeting. Washington, D.C.
Dec. 9-10 EuroConference: Stem cells. Paris, France
Dec. 9-10 DIA/EMEA Workshop on Gene Therapy & Cell Therapy Products. London, UK.
Oct. 5-Nov. 15 The Zitter Group: Managed Care Webcast Series - New series for biotech and pharma marketers aiming to enhance reimbursement, coverage, managed care strategy, and tactical effectiveness.
Nov. 29-Dec. 1: Current Good Tissue Practice- Amsterdam, Netherlands
Nov. 30-Dec. 1: Monitoring Clinical Trials - Malvern, Pa.
cGMP in the Transfusion Service. An online training course. link
NIH and other stem stem cell training courses - link
Weekly - UCSFs Human Embryonic Stem Cell Training Program (3-day training course). link
Jan. 17-28, BMRC-EMBO Practical Course on Advanced Optical Methods in Cell and Developmental Biology. Biopolis, Singapore
Application deadline: Nov. 15, 2004 (Selected Participants pay only travel costs)
Jan. 24-26 Phacilitate Cell & Gene Therapy Forum. Washington DC
February 10 - 15, 2005 Molecular Regulation of Stem Cells. Banff, Alberta
Feb. 10-14 Tandem BMT Meetings (Combined ASBMT and IBMTR/ABMTR annual meetings). Keystone, Colo.
Feb. 23-25: The Clinical Trials Congress - Philadelphia
Featuring 80+ leading clinical experts incorporating Clinical Technologies, Patient Recruitment, Regulations, Strategic Partnerships, Study Design & Management and Contracts and Budgeting into 4 dynamic tracks. Janet Woodcock, MD, CBER, FDA provides a highly-anticipated update on the FDA Clinical Path Initiative.
March 4-5 Stem Cell 2005: Progress to Therapy? EICC, Edinburgh, Scotland
March 16-20 American Society of Transplantation (AST) and Canadian Society of Transplantation (CST) Annual Winter Symposium. Banff, Canada.
March 20–23 European Group for Blood & Marrow Transplantion Annual Mtg. Prague, Czech Republic.
April 27-30 American Society for Apheresis 26th Annual Meeting Chicago, IL.
May 18-20 2nd World Congress on Regenerative Medicine. Leipzig, Germany.
May 3-7. 11th Annual Meeting and Scientific Conference of the International Society for Cellular Therapy (ISCT) Vancouver, Canada. (combined with Good Tissue Practices Workshop & Flow Cytometry for HSC Transplantation Workshop)
June 1-5 American Society of Gene Therapy Annual Meeting. Saint Louis, MO.
June 23-25 3rd Annual Meeting of the International Society for Stem Cell Research. San Francisco, CA.
Sept. 21-25 International Society of Pediatric Oncology Conference. Vancouver, Canada.
Sept/Oct Second International Epithelial Mesenchymal Transfer Conference. Vancouver, Canada.
Read Cytotherapy in 2005!
Join ISCT ($130) and receive the journal as a benefit of membership
The Current Issue is: Volume 6, Number 5 / October 2004
Cytotherapy publishes original research, reviews, meeting reports, special focus issues and letters in the general field of cell therapy. The scope of the journal includes includes basic and applied research with hematopoietic and non-hematopoietic stem cells , immune cells, and antigen-presenting cells. Therapeutic topics within the scope of Cytotherapy include ex-vivo and in-vivo aspects of gene therapy, immunotherapy, stem cell transplantation and tissue regeneration. Cytotherapy particularly welcomes
contributions from researchers, clinicians, technicians and individuals involved in regulatory aspects of cell therapy.